Asia Pacific Burn Ointment Market By Depth of Burn (Minor Burns, Partial Thickness Burns and Full Thickness Burns), By Product (Topical Antibiotics, Silver, Iodine and Other Products), By End Use (Clinics, Hospitals and Other End Use), By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Burn Ointment Market
The Asia Pacific Burn Ointment Market would witness market growth of 7% CAGR during the forecast period (2020-2026). The risk of hospital-acquired infections (HAI) is one of the major challenges that is faced by patients with burn injuries. The highest revenue in the burn injury treatment market is generated from hospitals. The healthcare providers in hospitals and clinics are providing topical treatments in order to reduce the incidences of hospital-acquired infections.
To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are looking towards the expertise of scientists and researchers to do experiments on silver-containing dressings with honey, since honey offers antiseptic effects that causes faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.
As the number of cases of blaze wounds is increasing, the demand for its treatment options are also increasing and therefore in coming years the overall healthcare expenditure on blaze wound care is expected to rise. The blaze wound care can be treated by using biologics, advanced dressings, and traditional blaze wound care products. In both hospitals and home-care settings, burn ointments are used as first aid.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Depth of Burn
- Minor Burns
- Partial Thickness Burns
- Full Thickness Burns
- Topical Antibiotics
- Other Products
By End Use
- Other End Use
- South Korea
- Rest of Asia Pacific
- Johnson and Johnson
- ConvaTec Group PLC
- Smith & Nephew PLC
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Perrigo Company PLC
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Morepen Limited
- Mankind Pharma Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free